JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up

@article{Coppola2017JWH122CA,
  title={JWH-122 Consumption Adverse Effects: A Case of Hallucinogen Persisting Perception Disorder Five-Year Follow-Up},
  author={M. Coppola and R. Mondola},
  journal={Journal of Psychoactive Drugs},
  year={2017},
  volume={49},
  pages={262 - 265}
}
  • M. Coppola, R. Mondola
  • Published 2017
  • Medicine
  • Journal of Psychoactive Drugs
  • ABSTRACT Synthetic cannabinoid receptor agonists are a heterogeneous group of psychotropic drugs functionally related to Δ9-tetrahydrocannabinol. These substances, marketed as cannabis substitutes, have been associated with numerous cases of severe intoxication and death across the world. In our article, we describe a case of hallucinogen persisting perception disorder developing in a natural cannabis user after consumption of JWH-122, a naphthoylindole largely used since 2010. Clinical… CONTINUE READING
    5 Citations

    References

    SHOWING 1-10 OF 13 REFERENCES
    Synthetic Cannabis Substances (SPS) Use and Hallucinogen Persisting Perception Disorder (HPPD): Two Case Reports.
    • 10
    Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases
    • 29
    • Highly Influential
    • PDF
    Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
    • 377
    • Highly Influential
    Pharmacology, Toxicology, and Adverse Effects of Synthetic Cannabinoid Drugs.
    • 204
    • PDF
    Ophthalmological assessment of cannabis-induced persisting perception disorder: Is there a direct retinal effect?
    • 18
    • Highly Influential
    The positive and negative syndrome scale (PANSS) for schizophrenia.
    • 15,642
    • PDF
    3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
    • 130
    • PDF
    The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.
    • 16,440
    • Highly Influential